Significant Wealth Partners’s Mereo BioPharma MREO Stock Holding History

Significant Wealth Partners’s Portfolio MREO Stock Details MREO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.4K	Buy	32,677 +7,043	+27%	+$2.11K	0.01%	116
2026 Q1	$8.46K	Buy	25,634 +3,945	+18%	+$1.69K	0.01%	111
2025 Q4	$9.04K	Sell	21,689 -26,125	-55%	-$49.7K	0.01%	70
2025 Q3	$98.5K	Buy	47,814 +25,553	+115%	+$47.1K	0.05%	102
2025 Q2	$60.3K	Buy	22,261 +8,490	+62%	+$20.5K	0.03%	95
2025 Q1	$31K	Buy	13,771 +2,966	+27%	+$8.39K	0.02%	91
2024 Q4	$37.8K	Buy	+10,805	New	+$42.5K	0.02%	83

Other funds holding MREO

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Significant Wealth Partners's MREO Position: Q2 2026 in Review

Significant Wealth Partners increased its Mereo BioPharma (MREO) stake by 27% in Q2 2026, buying an estimated $2.11K and bringing the position to 32,677 shares worth $10.4K. The position accounts for 0.01% of the portfolio, ranked #116.

Significant Wealth Partners first reported a position in MREO in Q4 2024 and has held it in 7 quarters since. The position peaked at $98.5K in Q3 2025. 2 funds tracked by Wall St. Rank hold MREO as of Q2 2026.

Significant Wealth Partners held 32,677 shares of Mereo BioPharma worth $10.4K as of Q2 2026.
Significant Wealth Partners bought 7,043 Mereo BioPharma shares in Q2 2026, an estimated $2.11K.
Mereo BioPharma made up 0.01% of Significant Wealth Partners's portfolio in Q2 2026, its #116 holding.
Significant Wealth Partners first reported a position in Mereo BioPharma in Q4 2024 and has held it in 7 quarters since.
Significant Wealth Partners's Mereo BioPharma position peaked at $98.5K in Q3 2025.
2 funds tracked by Wall St. Rank held Mereo BioPharma as of Q2 2026.

Based on Significant Wealth Partners's 13F filing for Q2 2026, filed 14 Jul 2026.